Particle.news

Download on the App Store

Ann Lally Defies Pancreatic Cancer Prognosis With Sustained Tumour Control

Under routine three-monthly surveillance with stable scans, now off active treatment, Lally resumes travel and family life beyond her initial life expectancy.

Overview

  • After six months of fortnightly chemotherapy at The Christie NHS Foundation Trust, Lally’s tumours had shrunk by 42% as of February 2025.
  • She now undergoes three-monthly surveillance with stable scans and no active medication after finishing her treatment.
  • Lally has outlived her initial six-to-12-month prognosis, travelling abroad, hosting gatherings and meeting her first grandson in June.
  • Her late husband, Mike, faced the same diagnosis but could not receive treatment due to severe COPD and died in March 2024.
  • Clinicians highlight that early diagnosis and specialist interventions like chest ports and home-deliverable chemotherapy can improve outcomes and quality of life in advanced pancreatic cancer.